Clinical Trials: Find a Clinical Trial

At any time Memorial Sloan Kettering Cancer Center is conducting hundreds of clinical trials to improve care for many types of cancer. Use the tool below to browse our clinical trials that are currently enrolling new patients. Each listing explains the purpose of the trial, the trial’s eligibility criteria, and how to get more information.

The list below includes clinical trials for adult cancers. Please visit our pediatric cancer care section to find a pediatric clinical trial.

Showing 461 - 480 of 490 trials
Titlesort icon Investigator Disease(s)
Memorial Sloan-Kettering Cancer Center Pancreatic Tumor Registry
[Protocol 02-102]
Kurtz, Robert
  • Hepatobiliary
    • Pancreatic Cancer
  • Hereditary Cancer & Genetics
  • Upper Gastrointestinal
    • Pancreatic Cancer
Microvascular Reconstruction for Advanced-Stage Head and Neck Cancer Patients: A Prospective Analysis of Quality of Life and Symptom Relief
[Protocol 07-150]
Pusic, Andrea
  • Head & Neck Cancer
  • Quality of Life
Molecular Characterization of Neuroblastic Tumors and Clinical Outcome
[Protocol 00-109]
Cheung, Nai-Kong
  • Neuroblastoma
Molecular Mechanisms of Clinical Resistance to Anti-HER2 Therapy Among Patients with HER2-Amplified Breast Cancer
[Protocol 06-163]
Chandarlapaty, Sarat
  • Breast Cancer
Neuropsychological, Social, Emotional, and Behavioral Outcomes in Children with Cancer (ALTE07C1)
Newly Diagnosed
[Protocol 12-241]
Dunkel, Ira
  • Survivorship
Ofatumumab with or without Bendamustine for Patients with Mantle Cell Lymphoma Who Cannot Have an Autologous Stem Cell Transplant
Newly Diagnosed
[Protocol 11-050]
Hamlin, Paul
  • Lymphoma
    • Non-Hodgkin's Lymphoma
PDX-017: A Phase III Study of Pralatrexate Versus Observation in Patients with Peripheral T-Cell Lymphoma Following Initial Chemotherapy
Newly Diagnosed & Relapsed/Refractory
[Protocol 10-212]
Horwitz, Steven
  • Lymphoma
    • Non-Hodgkin's Lymphoma
Phase I Study of Olaparib in Combination with Chemotherapy in Patients Newly Diagnosed with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 10-220]
Konner, Jason
  • Ovarian Cancer
Prognostic Awareness and Patient-Physician Communication in Malignant Glioma
[Protocol 13-253]
Diamond, Eli
  • Brain Tumors, Primary
    • Gliomas
  • Quality of Life
Prospective Ascertainment for Late Effects Among Cancer Survivors
[Protocol 12-143]
Tonorezos, Emily
  • Survivorship
Prostate Cancer Treatment Decision-Making and Survivorship
[Protocol 11-058]
Nelson, Christian
  • Prostate Cancer
    • Localized Disease
    • Quality of Life
  • Survivorship
Quality of Life and Patient-Reported Outcomes After Breast Reconstruction Surgery
[Protocol 12-093]
Pusic, Andrea
  • Breast Cancer
  • Quality of Life
  • Survivorship
Quality of Life Assessment in Breast Cancer Patients with Radiation-Induced Telangiectasias Treated with Pulsed Dye Laser
[Protocol 13-013]
Lee, Erica
  • Breast Cancer
  • Quality of Life
  • Survivorship
Quality of Life Outcomes Following Minimally Invasive versus Open Esophagectomy for Esophageal Cancer
[Protocol 12-003]
Rizk, Nabil
  • Quality of Life
  • Upper Gastrointestinal
    • Esophageal Cancer
Quit IT: Testing of a Web-based Coping Skills Game to Help Smokers Hospitalized for Cancer to Quit Smoking
[Protocol 14-062]
Ostroff, Jamie
  • Tobacco Cessation
Renal Tumor Classification, Biology, and Banking Study
[Protocol 12-014]
Kobos, Rachel
  • Kidney Cancer
Risk for Cognitive Decline in Older Women with Breast Cancer
[Protocol 10-079]
Ahles, Tim
  • Breast Cancer
Standard Infusion Carboplatin versus Prophylactic Extended Infusion Carboplatin in the Treatment of Patients with Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
[Protocol 10-184]
O'Cearbhaill, Roisin
  • Ovarian Cancer
Surviving Oropharynx Cancer: Long-Term Impact of Human Papillomavirus on Quality of Life
[Protocol 10-111]
Baxi, Shrujal
  • Head & Neck Cancer
  • Quality of Life
  • Survivorship
Targeted Silica Nanoparticles for Image-Guided Sentinel Lymph Node Mapping During Surgery in Patients with Melanoma of the Head and Neck
Newly Diagnosed & Relapsed/Refractory
[Protocol 13-249]
Bradbury, Michelle
  • Melanoma